Oral Proton Pump Inhibitor for Treatment of Congenital Chloride Diarrhea
Neonatal Medicine
;
: 59-63, 2016.
Article
Dans Anglais
| WPRIM
| ID: wpr-64999
ABSTRACT
Congenital chloride diarrhea (CCD) is a rare autosomal recessive disease, which is characterized by electrolyte absorption defect due to impaired function of the Cl-/HCO3 - exchanger in the ileum and the colon. Its main features are profuse watery diarrhea, high fecal chloride concentration, and failure to thrive. Profuse watery diarrhea characterized by a high concentration of chloride in stools results in hypochloremia, hyponatremia, and dehydration with metabolic alkalosis. Early detection and therapeutic intervention can prevent life-threatening symptoms of CCD and growth failure. Recently, several therapies, such as proton pump inhibitors and butyrate, have been suggested for amelioration of diarrhea. Here, we report a case of CCD in a preterm male infant who was successfully treated with an oral proton pump inhibitor.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
Sujet Principal:
Protons
/
Oméprazole
/
Butyrates
/
Pompes à protons
/
Côlon
/
Déshydratation
/
Diarrhée
/
Absorption
/
Alcalose
/
Retard de croissance staturo-pondérale
Type d'étude:
Étude de dépistage
Limites du sujet:
Humains
/
Bébé
/
Mâle
langue:
Anglais
Texte intégral:
Neonatal Medicine
Année:
2016
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS